Results 341 to 350 of about 7,897,516 (385)

Two‐Year Follow‐Up of a Multidisciplinary Lifestyle Intervention for Rheumatoid Arthritis and Osteoarthritis

Arthritis Care &Research, EarlyView.
Objective The Plants for Joints (PFJ) intervention, including a whole‐food plant‐based diet, exercise, and stress reduction, reduced signs and symptoms of rheumatoid arthritis (RA) or metabolic syndrome–associated hip or knee osteoarthritis (MSOA) compared to usual care.
Carlijn A. Wagenaar, Wendy Walrabenstein, Marike van der Leeden, Franktien Turkstra, Martijn Gerritsen, Jos W. R. Twisk, Maarten Boers, Martin van der Esch, Henriët van Middendorp, Peter J. M. Weijs, Dirkjan van Schaardenburg   +10 more
wiley   +1 more source

Adherence to mass drug administration and environmental factors related to lymphatic filariasis incidence: A case-control study in endemic area, Papua, Indonesia. [PDF]

Narra J
Wayangkau EC, Budiyono B, Raharjo M, Martini M.   +3 more
europepmc   +1 more source

Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications

Blood Advances, 2018
E. Dianne Pulte, Lei Nie, Nicole Gormley, Kirsten B. Goldberg, Amy McKee, Ann Farrell, Richard Pazdur   +6 more
doaj  

Transparency of artificial intelligence/machine learning-enabled medical devices

npj Digital Medicine
Aubrey A. Shick, Christina M. Webber, Nooshin Kiarashi, Jessica P. Weinberg, Aneesh Deoras, Nicholas Petrick, Anindita Saha, Matthew C. Diamond   +7 more
doaj   +1 more source

Late adverse event reporting from medical device manufacturers to the US Food and Drug Administration: cross sectional study.

BMJ
Everhart AO, Karaca-Mandic P, Redberg RF, Ross JS, Dhruva SS.   +4 more
europepmc   +1 more source

Enhanced Ocular Bioavailability and Prolonged Duration via Hydrophilic Surface Nanocomposite Vesicles for Topical Drug Administration. [PDF]

Pharmaceutics
Huang S, Xu Y, Luo Y, Wang Z, Li F, Qin Z, Ban J.   +6 more
europepmc   +1 more source

Prevention and improved management of serious neurological adverse events during praziquantel-based mass drug administration in a Taenia solium endemic area: Experiences from Madagascar. [PDF]

PLoS Negl Trop Dis
Nely JA, Ramiandrasoa NS, Andria-Mananjara DE, Edosoa G, Rasoamihanta Martin P, Abela B, Donadeu M, Fleury A.   +7 more
europepmc   +1 more source

Strength of clinical evidence supporting the United States Food and Drug Administration Accelerated Approvals from 2015 to 2022. [PDF]

BMC Med
Zhang X, Peck CC, Wang Y, Szucs TD, Sun W, Bai X, Chen S, Wang F, Wu Y.   +8 more
europepmc   +1 more source

Disproportionality analysis of Raynaud's phenomenon associated with calcitonin gene-related peptide inhibitors using the Food and Drug Administration adverse event reporting system. [PDF]

Sci Rep
Lee N, Ok JH, Rhee SJ, Kim Y.
europepmc   +1 more source

Recent Use of Novel Data Streams During Foodborne Illness Cluster Investigations by the United States Food and Drug Administration: Qualitative Review.

JMIR Public Health Surveill
Bazaco MC, Carstens CK, Greenlee T, Blessington T, Pereira E, Seelman S, Ivory S, Jemaneh T, Kirchner M, Crosby A, Viazis S, van Twuyver S, Gwathmey M, Malais T, Ou O, Kenez S, Nolan N, Karasick A, Punzalan C, Schwensohn C, Gieraltowski L, Chen Parker C, Jenkins E, Harris S.   +23 more
europepmc   +1 more source